1[1]Williams B.Recent hypertension trials[J].J Am Coll Cardiol,2005,45:813-827.
2[2]Chobanian AV,Bakris GL,Black HR,et al.The seventh report of the joint national committee on prevention,detection,evaluation,and treatment of high blood pressure:the JNC 7 report[J].JAMA,2003,290:197.
3[3]Staessen JA,Wang JG,Thijs L,et al.Cardiovascular prevention and blood pressure reduction:a quantitative overview updated until 1st March 2003[J].J Hypertens,2003,21:1055-1076.
4[4]Julius S,Kjeldsen SE,Weber M,et al.Outcomes in hypertensive patients at high cardiovascular risk treated with regiments based on vasartan or amlodipine:the VALUE randomed trial[J].Lancet,2004,363:2022-2031.
5[5]Blood Pressure Lowering Treatment Trialists Collaboration.Effects of different blood pressure lowering regiments on major cardiovascular events:results of prospectively designed overviews of randomised trials[J].Lancet,2003,362:1527-1545.
6[6]The ALLHAT Officers and Coordinators for the ALLHAT Collabrative Research Group.Major outcomes in high-risk hypertensive patients randomised to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic:the Antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT)[J].JAMA,2002,288:2981-2997.
7[7]Vasan RS,Larson MG,Leip EP,et al.Impact of high normal BP on the risk of cardiovascular disease[J].N Engl J Med,2001,345:1903-1907.
8[8]Hansson L,Hednet T,Jonhanson PL,et al.Randomised trial of effects of calcium antagonists compared with diuretics and beta blockers on cardiovascular morbidity and mortality in hypertension:the Nordic Diltiazem (NORDIL) study[J].Lancet,2000,356:359-365.
9[9]Dalholof B,Sever PS,Poulter NR,et al.Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflurnethiazide as required,in the Anglo-Scandinavian cardiac outcomes trial blood pressure lowering arm (ASCOT-BPLA):a multicentre randomised controlled trial[J].Lancet,2005,366:899-906.
10[10]Liu LS,Zhang YQ,Liu GZ,et al.The felodipine event reduction (FEVER) study:a randomized long-term placebo-controlled trial in Chinese hypertensive patients[J].J hypertens,2005,23:2157-2172.
